Novel Insights into the Molecular Regulation of Ribonucleotide Reductase in Adrenocortical Carcinoma Treatment.

Cancers (Basel) · 2021 · PMC8391410 · PMID 34439352

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

While, e.g., E or C inhibited the cell viability of NCI-H295R cells in a highly significant (E 180 uM: 2.5%; C 160 μM: 17%) and dose-dependent manner, even at extraordinarily high drug concentrations, cell viability remained high for MUC-1 (E 180 μM: 67%; C 160 μM: 70%; both p < 0.001 vs.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.